Two- to five-year follow-up of 78 patients after treatment with the Flow Redirection Endoluminal Device.
Hannes LückingArnd DoerflerPhilipp GoelitzPhilip HoelterTobias EngelhornStefan LangPublished in: Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences (2019)
Our long-term data covering two to five years after flow diversion confirm that Flow Redirection Endoluminal Device is a safe and effective device for the treatment of cerebral aneurysms with progressive high aneurysm occlusion rates; recurrence rates were very low. Overall device-related morbidity was low and was not observed later than six months after intervention.